spotlight what-to-watch 
XTalks
MARCH 19, 2024
This mirrors what happens in everyday clinical practice, where patients often receive multiple medications before finding an effective treatment. It is well established that drugs for psychiatric conditions suffer some of the lowest approval rates when compared to other major therapeutic areas.
Pharmaceutical Technology
JUNE 29, 2022
This year has already been eventful when it comes to the development of therapies for rare diseases. Additionally, pricing and access for rare disease therapies continue to be scrutinized closely. Most, if not all, of these therapies used the FDA’s Orphan Drug Designation to aid their development plans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
JANUARY 17, 2024
Changes in what clinical performance data is used to inform the trial design and site selection, new approaches to patient recruitment and the rise of advanced treatments such as cell and gene therapy are rewriting the script. Dr. Morrison and Dr. Vidal shared their insights from the 2023 ESMO conference which occurred in Madrid.
pharmaphorum
OCTOBER 1, 2022
With Frontiers Health 2022 mere weeks away, we continue to interview members of the steering committee, gaining insight into what to expect from Milan. We really are saying the ‘health industry’ and that is what gets us up in the morning.”. I don’t know if you ever watch Bachelor or Bachelorette,” he jokes. “My
XTalks
JANUARY 16, 2024
What if your team could capture objective physiological and behavioral study data from a diverse group of patients on an ongoing basis without them having to leave the comfort of their own homes? In this Xtalks Spotlight edition, Xtalks spoke with Dr. CJ Barnum, Vice President of CNS Development at INmune Bio, Inc.
XTalks
DECEMBER 4, 2023
Matthew Confeld, PharmD, PhD Assistant Director, Clinical Research Methodology, Worldwide Clinical Trials In this Xtalks Spotlight edition, Xtalks spoke with Matthew Confeld, PharmD, PhD, Assistant Director of Clinical Research Methodology at Worldwide Clinical Trials , about Project Optimus and what it means for oncology programs.
XTalks
NOVEMBER 27, 2023
In this Xtalks Spotlight feature, Xtalks spoke with Maria Madariaga, MD, Associate Medical Monitor, Neuroscience, Medical Affairs at Worldwide Clinical Trials. Solving the opioid epidemic long-term requires bringing new, safe and better treatments to market to replace the reliance on opioids in the clinical setting.
Expert insights. Personalized for you.
115 
Let's personalize your content